Antoine de LACHAUX

Is heading the life science and biotech unit within the venture debt division of the EIB since June 2023. Before that, he worked for seven years in the same team and was involved in multiple projects across the full spectrum of companies operating in the life science sector (biotech, medical devices, digital medicine). Before joining the EIB, Antoine worked in investment banking and in corporate finance advisory. His expertise is in finance and strategy. Antoine de Lachaux holds two Master of Science degrees in Finance from Montpellier Business School and Montpellier University.